Risk assessment and early risk predictors of bacterial infections in children undergoing cancer treatment.
Not Applicable
- Conditions
- Health Condition 1: D709- Neutropenia, unspecified
- Registration Number
- CTRI/2023/10/058866
- Lead Sponsor
- Dr Esha P Suresh
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Children <18years with cancer on treatment with febrile neutropenia admitted to the Department of Paediatrics and Paediatric haematoncology and Children <18 years in post transplant period with immunosuppression and febrile neutropenia admitted to the Department of Paediatric Haematoncology.
Exclusion Criteria
Children whose parents refuse to participate in the study and children with underlying syndromes and primary immunodeficiency.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To be able to predict the risk factors (IL6,CRP,CBC,PCT,RFT,LFT,Blood culture sensitivity) for early detection of bacterial infection in children with febrile neutropenia using the available variables. It will be assessed over a course of 1 week.Timepoint: Assessed at baseline and at the end of 1 week.
- Secondary Outcome Measures
Name Time Method To study the delay & dose variations in chemotherapy due to febrile neutropenic episodes. <br/ ><br>To study the need for reserved antibiotic use.Timepoint: Assessed at baseline & at the end of 1 week